Primary |
Blood Pressure Increased |
14.3% |
Bone Density Abnormal |
14.3% |
Coronary Artery Disease |
14.3% |
Face Lift |
14.3% |
Muscle Strain |
14.3% |
Myocardial Infarction |
14.3% |
Product Used For Unknown Indication |
14.3% |
|
Application Site Reaction |
12.5% |
Cardiac Arrest |
12.5% |
Cerebrovascular Accident |
12.5% |
Coronary Artery Bypass |
12.5% |
Fall |
12.5% |
Posterior Reversible Encephalopathy Syndrome |
12.5% |
Subcutaneous Abscess |
12.5% |
Thermal Burn |
12.5% |
|
Secondary |
Drug Use For Unknown Indication |
26.3% |
Hypertension |
15.8% |
Myocardial Ischaemia |
10.5% |
Pulmonary Hypertension |
10.5% |
Atrial Fibrillation |
7.9% |
Product Used For Unknown Indication |
7.9% |
Hypothyroidism |
5.3% |
Angina Pectoris |
2.6% |
Cardiovascular Event Prophylaxis |
2.6% |
Dementia Alzheimer's Type |
2.6% |
Depression |
2.6% |
Gastrooesophageal Reflux Disease |
2.6% |
Osteoporosis |
2.6% |
|
Hypotension |
33.3% |
Diabetes Mellitus |
20.0% |
Drug Hypersensitivity |
13.3% |
Bradyarrhythmia |
6.7% |
Bradycardia |
6.7% |
Insomnia |
6.7% |
Syncope |
6.7% |
Urticaria |
6.7% |
|
Concomitant |
Product Used For Unknown Indication |
31.9% |
Drug Use For Unknown Indication |
20.2% |
Hypertension |
10.4% |
Atrial Fibrillation |
5.1% |
Diabetes Mellitus |
4.0% |
Cardiac Disorder |
3.6% |
Myocardial Ischaemia |
3.1% |
Pain |
3.0% |
Thrombosis Prophylaxis |
2.6% |
Prophylaxis |
2.4% |
Angina Pectoris |
2.1% |
Cardiac Failure Chronic |
1.7% |
Depression |
1.6% |
Breast Cancer |
1.4% |
Chest Pain |
1.4% |
Systemic Sclerosis |
1.4% |
Major Depression |
1.1% |
Cardiac Failure |
1.0% |
Osteoporosis |
1.0% |
Rheumatoid Arthritis |
1.0% |
|
Myocardial Infarction |
11.1% |
Vomiting |
8.3% |
Weight Decreased |
8.3% |
Pulmonary Oedema |
7.4% |
Thrombocytopenia |
7.4% |
Anaemia |
6.5% |
Syncope |
6.5% |
Drug Interaction |
4.6% |
Therapeutic Agent Toxicity |
4.6% |
Type 2 Diabetes Mellitus |
4.6% |
Renal Failure |
3.7% |
Skin Exfoliation |
3.7% |
Urinary Incontinence |
3.7% |
Aplasia Pure Red Cell |
2.8% |
Bladder Cancer |
2.8% |
Cardiac Arrest |
2.8% |
Cardiac Failure |
2.8% |
Fall |
2.8% |
Heart Rate Increased |
2.8% |
Pain |
2.8% |
|
Interacting |
Hypertension |
28.6% |
Myocardial Ischaemia |
28.6% |
Prophylaxis |
28.6% |
Atrial Fibrillation |
14.3% |
|
Drug Interaction |
33.3% |
Hyperkalaemia |
33.3% |
Neuropathy Peripheral |
33.3% |
|